Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Austria
Clinical trial register · Austria

Clinical Trials in Austria

Every study on the ClinicalTrials.gov registry that lists a site in Austria and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 1581 matching records held by the registry are in this view. Synced 11 Nov 2026, 03:18 UTC
1581
Studies in scope
all four open statuses
849
Recruiting now
open to new participants
339
Lead sponsors
across recruiting studies
Top sites
Vienna 1011 Graz 514 Linz 434 Innsbruck 395 Salzburg 292
Narrow the register
Recruitment status
Phase
Lead sponsor
Medical University of Vienna146 Medical University of Graz86 AstraZeneca54 Medical University Innsbruck45 Novartis Pharmaceuticals40 AbbVie34 Hoffmann-La Roche31 Merck Sharp & Dohme LLC27 Eli Lilly and Company27 Bristol-Myers Squibb24 Janssen Research & Development, LLC24 Amgen21 Sanofi19 University Hospital, Basel, Switzerland16 Boehringer Ingelheim15 argenx15 Bayer15 Novo Nordisk A/S14 Incyte Corporation13 University of Vienna13 Takeda12 Pfizer11 Celgene10 Daiichi Sankyo10 Alexion Pharmaceuticals, Inc.9 Show all 533
Site location
Vienna1011 Graz514 Linz434 Innsbruck395 Salzburg292 Sankt Pölten115 Wels90 Klagenfurt64 Feldkirch50 Krems35 Wiener Neustadt34 Rankweil25 Leoben25 Braunau am Inn17 Steyr12 Sankt Veit an der Glan7 Mattersburg7 Vöcklabruck7 Schwaz7 Kufstein6 Dornbirn6 Mistelbach5 Tulln5 Wein5 Eisenstadt4 Show all 98
All 98 locations
Target enrolment
to

Trials in this register

1581 of 1581 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Austria
Start
Recruiting
Ketamine in OCD: Efficacy and Effects on Stress and Cognition
NCT05577585Obsessive-Compulsive Disorder, Psychiatric Disorder
DrugMidazolam
Medical University of Vienna
Not applicable
60
Vienna
2022-10-01
Active, closed
PedAL BCU, LLC
Phase 3
120
Vienna
2022-10-01
Recruiting
Celgene
Phase 3
810
Vienna, Krems, Leoben, Sankt Pölten
2022-09-20
Active, closed
Genmab
Phase 3
549
Sankt Pölten, Linz, Salzburg
2022-09-20
Active, closed
Janssen Research & Development, LLC
Phase 2
577
Salzburg, Vienna, Wels
2022-09-19
Recruiting
University of Ulm
Phase 3
650
Innsbruck, Linz, Rankweil, Salzburg, Vienna
2022-09-13
Active, closed
Study Evaluating LDL-C Change and Adherence to Inclisiran Lipid-lowering Therapy in ASCVD
NCT05399992Primary Hypercholesterolemia, Mixed Dyslipidemia
Novartis Pharmaceuticals
Observational
847
Feldkirch, Graz, Linz, Sankt Veit im Pongau, Vienna
2022-09-12
Active, closed
European Myeloma Network B.V.
Phase 3
1,594
Feldkirch, Innsbruck, Krems, Linz, Salzburg, Vienna
2022-09-08
Active, closed
Redx Pharma Ltd
Phase 2
48
Vienna
2022-09-08
Recruiting
Metabolomics Study on Postoperative Intensive Care Acquired Muscle Weakness
NCT03810768Metabolomics, Critical Care, Critical Illness, Critical Illness Myopathy
Technical University of Munich
Observational
20
Vienna
2022-09-02
Recruiting
Medical University of Vienna
Not applicable
30
Vienna
2022-09-01
By invitation
Ottawa Heart Institute Research Corporation
Observational
3,500
Vienna
2022-09-01
Recruiting
Haemoadsorption During Heart Transplantation
NCT05270902Heart Transplantation
Medical University of Vienna
Not applicable
40
Vienna
2022-09-01
Recruiting
Asciminib Roll-over Study
NCT04877522Chronic Myelogenous Leukemia, Leukemia, Myelogenous, Chronic, BCR-ABL Positive
DrugsAsciminib single agent·Bosutinib·ABL001·Nilotinib
Novartis Pharmaceuticals
Phase 4
347
Graz, Vienna
2022-08-30
Recruiting
Takeda
Phase 3
440
Graz, Neunkirchen
2022-08-24
Active, closed
AUVA Traumazentrum Vienna Site UKH Meidling
Phase 2
80
Vienna
2022-08-22
Recruiting
Bristol-Myers Squibb
Observational
1,700
Braunau am Inn, Graz, Innsbruck, Klagenfurt, Linz, Sankt Pölten, Vienna
2022-08-16
Active, closed
Novo Nordisk A/S
Phase 3
412
Linz, Dornbirn, Sankt Pölten, Vöcklabruck
2022-08-10
Recruiting
Fertility and the Microbiome
NCT05328999Subfertility, Asthenozoospermia
Medical University of Graz
Observational
300
Graz
2022-08-10
Recruiting
Study of Nab-Paclitaxel and Gemcitabine With or Without SBP-101 in Pancreatic Cancer
NCT05254171Pancreatic Cancer Metastatic, Pancreatic Ductal Adenocarcinoma, Pancreatic Cancer Stage IV
DrugsAbraxane·Nab-paclitaxel·Gemcitabine
Panbela Therapeutics, Inc.
Phase 2/3
600
Klagenfurt, Sankt Pölten, Linz, Steyr, Wels, Rankweil, Salzburg, Wein
2022-08-08
Recruiting
Infants With Severe Acute Respiratory Distress Syndrome: The Prone Trial
NCT05002478Acute Lung Injury/Acute Respiratory Distress Syndrome (ARDS), Surfactant Dysfunction, Infant
Medical University of Vienna
Not applicable
14
Vienna
2022-07-30
Recruiting
Susanne Rogers
Not applicable
200
Innsbruck
2022-07-29
Active, closed
Gilead Sciences
Phase 3
443
Innsbruck, Linz, Salzburg, Sankt Pölten, Vienna
2022-07-25
Active, closed
Janssen Research & Development, LLC
Phase 2
703
Salzburg, Vienna, Wels
2022-07-22
Recruiting
A Study of Pirtobrutinib (LOXO-305) Versus Ibrutinib in Participants With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)
NCT05254743Chronic Lymphocytic Leukemia, Leukemia, Lymphocytic, Leukemia, B-cell, Small Lymphocytic Lymphoma
DrugsPirtobrutinib·Ibrutinib
Loxo Oncology, Inc.
Phase 3
737
Vienna
2022-07-22
Recruiting
Ionis Pharmaceuticals, Inc.
Phase 1
40
Innsbruck
2022-07-21
Active, closed
STAR-LIFE: a Post-market Registry on MINIject
NCT05269680Open Angle Glaucoma
iSTAR Medical
Observational
320
Graz, Salzburg, Vienna
2022-07-20
Active, closed
Gilead Sciences
Phase 3
623
Innsbruck, Linz
2022-07-20
Active, closed
Incyte Corporation
Phase 1/2
53
Sankt Pölten, Wels, Salzburg
2022-07-19
Active, closed
GlaxoSmithKline
Phase 3
163
Graz
2022-07-14
Active, closed
Regeneron Pharmaceuticals
Phase 3
1,546
Sankt Pölten, Graz, Innsbruck, Vienna
2022-07-14
Active, closed
Novartis Pharmaceuticals
Phase 1/2
55
Vienna
2022-07-13
Active, closed
Daiichi Sankyo
Phase 3
586
Feldkirch, Innsbruck, Klagenfurt, Vienna, Wels
2022-07-08
Recruiting
Octapharma
Phase 3
38
Vienna
2022-07-01
Recruiting
M-ARS ACL Post-marketing Surveillance Study
NCT04462458Anterior Cruciate Ligament (ACL) Reconstruction
Medacta International SA
Observational
200
Innsbruck, Kirchdorf an der Krems
2022-07-01
Active, closed
Celgene
Phase 3
939
Graz, Linz, Salzburg, Sankt Pölten, Vienna
2022-06-23
Recruiting
CytOSorb TreatMent Of Critically Ill PatientS Registry
NCT05146336Septic Shock, Acute Respiratory Distress Syndrome, Trauma, Rhabdomyolysis
CytoSorbents, Inc
Observational
3,000
Klagenfurt, Vienna
2022-06-22
Recruiting
Hop Compounds on the Immune System (VH)
NCT06286644Inflammatory Response
University of Vienna
Not applicable
14
Vienna
2022-05-30
Active, closed
PASS of Paediatric Patients Initiating Selumetinib
NCT05388370Neurofibromatosis Type 1
AstraZeneca
Observational
124
Vienna
2022-05-23
Active, closed
Hoffmann-La Roche
Phase 3
188
Vienna
2022-05-19
Recruiting
Electra Therapeutics Inc.
Phase 2/3
156
Innsbruck, Vienna
2022-05-19
Recruiting
SELUTION4BTK Trial
NCT05055297Peripheral Arterial Disease, Chronic Limb-Threatening Ischemia Nos of Native Arteries of Extremities
M.A. Med Alliance S.A.
Not applicable
376
Graz
2022-05-19
Active, closed
Shanghai Henlius Biotech
Phase 3
511
Klagenfurt, Vienna
2022-05-17
Recruiting
EBG MedAustron GmbH
Not applicable
30
Wiener Neustadt
2022-05-16
Recruiting
Innovacell GmbH
Phase 3
290
Graz, Hall in Tirol
2022-05-11
Active, closed
Hoffmann-La Roche
Phase 3
1,300
Innsbruck, Linz, Vienna
2022-05-03
Active, closed
Sanofi
Phase 3
104
Graz
2022-05-03
Active, closed
Pierre Fabre Medicament
Phase 3
815
Graz, Linz, Sankt Pölten, Vienna
2022-05-02
Active, closed
Evolut™ EXPAND TAVR II Pivotal Trial
NCT05149755Moderate Aortic Valve Stenosis
Medtronic Cardiovascular
Not applicable
650
Sankt Pölten, Vienna
2022-04-27
Recruiting
Zanubrutinib in Patients With Waldenström's Macroglobulinemia, Chronic Lymphocytic Leukemia, Marginal Zone Lymphoma and Follicular Lymphoma
NCT05326308Waldenström's Macroglobulinemia, Chronic Lymphocytic Leukemia, Marginal Zone Lymphoma, Follicular Lymphoma
DrugsZanubrutinib·Obinutuzumab
iOMEDICO AG
Observational
845
Salzburg
2022-04-26
Recruiting
Nanopore Sequencing in Ophthalmology
NCT05372861Endophthalmitis
Medical University of Graz
Observational
20
Graz
2022-04-22
Recruiting
Retrospective Prospective Multicentric Clinical Follow up of Patients After Being Treated With TricValve®
NCT05114850Tricuspid Regurgitation, Tricuspid Valve Insufficiency, Tricuspid Insufficiency, Heart Failure
P+F Products + Features GmbH
Observational
450
Sankt Pölten, Vienna
2022-04-20
Recruiting
The Basel CardioInsightTM - 3D Mapping Study
NCT04964765New-onset Atrial Fibrillation (NOAF)
University Hospital, Basel, Switzerland
Observational
157
Sankt Pölten
2022-04-12
Recruiting
Zimmer Biomet
Observational
500
Innsbruck
2022-04-11
Recruiting
Ethicon Pelvic Mesh Post Market Clinical Follow-up Registry
NCT04829175Stress Urinary Incontinence, Pelvic Organ Prolapse
Ethicon, Inc.
Observational
1,000
Linz
2022-04-11
Active, closed
Protagonist Therapeutics, Inc.
Phase 3
293
Graz, Linz, Vienna, Wels
2022-04-11
Recruiting
The DRAGON 2 Trial
NCT05428735Colorectal Cancer Liver Metastases (CRLM), Small Future Liver Remnant (FLR)
Maastricht University
Not applicable
348
Vienna
2022-04-01
Recruiting
Medical University of Vienna
Not applicable
8
Vienna
2022-04-01
Active, closed
Bayer
Phase 3
219
Vienna, Graz, Innsbruck
2022-03-28
Recruiting
AbbVie
Phase 2
75
Sankt Pölten, Vienna, Leoben, Linz, Salzburg
2022-03-28
Recruiting
AbbVie
Phase 3
768
Vienna, Innsbruck, Linz, Wels, Feldkirch, Salzburg
2022-03-25
Recruiting
MicroPort CRM
Observational
206
Krems, Vienna
2022-03-25
Active, closed
Pfizer
Phase 3
854
Vienna
2022-03-25
Active, closed
Merck Sharp & Dohme LLC
Phase 3
460
Graz, Linz, Vienna
2022-03-24
Recruiting
Johannes Kepler University of Linz
Observational
392
Linz
2022-03-21
Active, closed
Sanofi
Phase 3
122
Vienna
2022-03-11
Active, closed
BeOne Medicines
Phase 3
799
Innsbruck, Sankt Pölten, Vienna
2022-03-10
Active, closed
A Phase 3 Study to Examine the Efficacy and Safety of ZX008 in Subjects With CDKL5 Deficiency Disorder.
NCT05064878CDKL5 Deficiency Disorder, Generalized Tonic Clonic Seizure, Epileptic Spasm, Refractory Seizures
DrugFintepla
Zogenix, Inc.
Phase 3
87
Linz
2022-03-08
Active, closed
Seagen, a wholly owned subsidiary of Pfizer
Phase 3
654
Schwaz, Graz, Linz, Vienna
2022-03-07
Active, closed
Daiichi Sankyo
Phase 3
740
Klagenfurt, Vienna
2022-03-04
Active, closed
A Phase 3 Single-Arm Study of UGN-102 for Treatment of Low-Grade Intermediate-Risk Non-Muscle Invasive Bladder Cancer
NCT05243550Bladder Cancer, Urothelial Carcinoma, Urothelial Carcinoma Bladder
UroGen Pharma Ltd.
Phase 3
240
Vienna
2022-03-01
Active, closed
Jena University Hospital
Not applicable
230
Vienna
2022-02-10
Recruiting
Medial Displacement Calcaneal Osteotomy and FDL- Transfer - With a Human, Allogeneic Cortical Bone Screw
NCT05643079Flat Feet, Flexor Tendon Rupture, Tibialis Posterior Dysfunction, Deformity, Foot
Orthopedic Hospital Vienna Speising
Observational
40
Vienna
2022-02-10
Active, closed
Optimized CT-imaging Protocol in VA-ECMO Patients After CPR
NCT05290805Cardiopulmonary Arrest, VA-ECMO
Medical University of Vienna
Not applicable
50
Vienna
2022-02-01
Active, closed
Amgen
Phase 1/2
329
Graz, Salzburg
2022-02-01
Recruiting
Alexandra Kautzky-Willer
Phase 4
32
Vienna
2022-01-25
Active, closed
OncoBeta Therapeutics
Not applicable
210
Ottakring
2022-01-17
Recruiting
The "Global Paradise System" Registry
NCT05027685Hypertension
ReCor Medical, Inc.
Observational
3,000
Vienna, Wels
2022-01-13
Recruiting
Azienda Ospedaliero-Universitaria Careggi
Observational
10,000
Vienna
2022-01-10
Recruiting
EUROSETS ECMO Study in Clinical Extracorporeal Life Support Applications
NCT05163925Extracorporeal Membrane Oxygenation Complication
Eurosets S.r.l.
Observational
30
Vienna
2022-01-10
Recruiting
Medical University of Vienna
Observational
300
Vienna
2022-01-10
Recruiting
Predictive and Advanced Analytics in Emergency Medicine - Neurological Deficits
NCT06245694Artificial Intelligence, Resource Allocation, Neurologic Manifestations
Medical University of Vienna
Observational
50,000
Vienna
2022-01-01
Active, closed
Eli Lilly and Company
Phase 3
152
Feldkirch, Vienna
2021-12-20
Active, closed
MED-EL Elektromedizinische Geräte GmbH
Observational
384
Vienna
2021-12-16
Active, closed
Novartis Pharmaceuticals
Phase 3
1,000
Linz
2021-12-16
Recruiting
Karl Landsteiner University of Health Sciences
Observational
100
Tulln
2021-12-15
By invitation
Long-Term Follow-Up Study After Gene-Modified Cell Treatment in Kite Studies
NCT05041309Solid and Hematological Malignancies, Autoimmune Diseases
DrugsKITE-197·SPRX002·KITE-753·Tecartus
Kite, A Gilead Company
Observational
1,500
Innsbruck
2021-12-15
Recruiting
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
NCT05176483Renal Cell Carcinoma (RCC), Metastatic Castration-Resistant Prostate Cancer (mCRPC), Urothelial Carcinoma (UC), Solid Tumor
DrugsZanzalintinib·Relatlimab·Yervoy·Ipilimumab
Exelixis
Phase 1
1,394
Graz, Salzburg, Vienna, Wein
2021-12-14
Recruiting
Intraindividual Comparison of EMO IOLs
NCT05822089Age Related Cataracts
Medical University of Vienna
Not applicable
461
Vienna
2021-12-13
Recruiting
Johnson & Johnson Enterprise Innovation Inc.
Phase 3
500
Graz, Innsbruck, Linz, Vienna
2021-12-10
Active, closed
Sanofi
Phase 2
22
Vienna
2021-12-07
Active, closed
Abivax S.A.
Phase 2
203
Innsbruck, Vienna
2021-12-03
Active, closed
A Phase 2 Study of Tarlatamab in Patients With Small Cell Lung Cancer (SCLC)
NCT05060016Relapsed/Refractory Small Cell Lung Cancer
DrugTarlatamab
Amgen
Phase 2
222
Krems, Salzburg
2021-12-01
Recruiting
Blueprint Medicines Corporation
Phase 2/3
534
Linz
2021-11-30
Recruiting
Medical University Innsbruck
Observational
1,000
Innsbruck
2021-11-30
Active, closed
Novartis Pharmaceuticals
Phase 3
17,004
Braunau am Inn, Graz
2021-11-23
Active, closed
Janssen Pharmaceutica N.V., Belgium
Observational
256
Leoben, Vienna
2021-11-18
Active, closed
Gilead Sciences
Phase 3
603
Innsbruck, Salzburg, Vienna
2021-11-17
Recruiting
Insel Gruppe AG, University Hospital Bern
Phase 3
70
Innsbruck, Linz, Vienna
2021-11-16
Recruiting
Medical University of Vienna
Observational
300
Vienna
2021-11-11
Recruiting
(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis
NCT04996875Advanced Systemic Mastocytosis (AdvSM), SM With an Associated Hematologic Neoplasm (SM-AHN), Mast Cell Leukemia (MCL), Aggressive Systemic Mastocytosis (ASM)
DrugBezuclastinib
Cogent Biosciences, Inc.
Phase 2
140
Vienna
2021-11-09
Active, closed
Amgen
Phase 3
303
Graz, Innsbruck, Linz, Vienna
2021-11-02
Active, closed
Pre-op Fluid Study
NCT05079269Hypotension Drug-Induced, Anesthesia
Medical University of Graz
Not applicable
550
Vienna, Graz
2021-11-01
Active, closed
AstraZeneca
Phase 3
454
Linz, Vienna
2021-10-28
Active, closed
GWT-TUD GmbH
Phase 3
70
Innsbruck, Vienna
2021-10-27
Active, closed
argenx
Phase 2/3
15
Vienna
2021-10-26
Active, closed
International Extranodal Lymphoma Study Group (IELSG)
Phase 2
26
Vienna
2021-10-20
Active, closed
Arbeitsgemeinschaft medikamentoese Tumortherapie
Phase 2
198
Kufstein, Leoben, Mitterweng, Salzburg, Sankt Pölten, Vienna, Zams
2021-10-20
Recruiting
Medical University of Vienna
Observational
140
Vienna
2021-10-15
Recruiting
St George's, University of London
Not applicable
222
Innsbruck, Linz, Salzburg, Sankt Pölten
2021-10-08
Recruiting
Niguarda Hospital
Phase 3
288
Graz, Innsbruck, Vienna
2021-10-07
Active, closed
A Study of Oral Asciminib Versus Other TKIs in Adult Patients With Newly Diagnosed Ph+ CML-CP
NCT04971226Chronic Myeloid Leukemia (CML) Philadelphia Chromosome Positive
DrugsBosutinib·Asciminib·ABL001·Nilotinib
Novartis Pharmaceuticals
Phase 3
405
Linz
2021-10-06
Active, closed
Novartis Pharmaceuticals
Phase 3
129
Vienna
2021-10-05
Active, closed
Eli Lilly and Company
Phase 3
874
Vienna, Graz, Salzburg
2021-10-04
Recruiting
Pfizer
Phase 3
893
Krems, Vienna, Innsbruck, Salzburg
2021-10-04
Recruiting
Medical University of Graz
Observational
600
Graz, Innsbruck, Salzburg
2021-10-01
Active, closed
Safe and Timely Antithrombotic Removal (STAR) Registry
NCT05077124Hemorrhage, Surgical, Hemorrhage Postoperative, Blood Loss, Surgical, Blood Loss, Postoperative
CytoSorbents, Inc
Observational
1,000
Graz, Innsbruck, Vienna
2021-09-30
Active, closed
Loxo Oncology, Inc.
Phase 3
282
Salzburg, Vienna
2021-09-23
Active, closed
Cardiovascular and InflammAging Study
NCT04763291Aging, Cardiovascular Diseases, Overweight or Obesity
Green Beat
Not applicable
80
Graz
2021-09-01
Recruiting
Moving Towards Precision Medicine in United Airways Disease: Unraveling Inflammatory Patterns in Asthmatic Patients With or Without Nasal Polyps
NCT05009758Asthma, Chronic Rhinosinusitis With Nasal Polyps, Chronic Rhinosinusitis (Diagnosis), Nasal Polyps
Medical University of Vienna
Not applicable
30
Vienna
2021-09-01
Active, closed
Hoffmann-La Roche
Phase 3
4,170
Graz, Innsbruck, Rankweil, Salzburg, Sankt Pölten, Sankt Veit im Pongau, Steyr, Vienna
2021-08-27
Active, closed
Janssen Pharmaceutica N.V., Belgium
Observational
1,314
Graz, Linz, Vienna
2021-08-25
Active, closed
STOP Persistent AF PAS
NCT05005949Persistent Atrial Fibrillation
Medtronic Cardiac Ablation Solutions
Observational
393
Linz
2021-08-19
Active, closed
Merck Sharp & Dohme LLC
Phase 1/2
110
Vienna
2021-08-19
Active, closed
Janssen Research & Development, LLC
Phase 3
743
Graz, Linz, Salzburg, Vienna
2021-08-19
Recruiting
Miltenyi Biomedicine GmbH
Phase 2
213
Graz, Innsbruck, Linz, Vienna
2021-08-18
Active, closed
Christian Buske
Phase 2
99
Salzburg, Vienna
2021-08-18
Recruiting
Study of the R3 Vascular Drug-Eluting Bioresorbable Scaffold in Treating Below the Knee Arterial Disease
NCT04912323Peripheral Arterial Disease, Atherosclerotic Lesion, Lower Extremity Ischemia, Lower Extremity Claudication
R3 Vascular Inc.
Not applicable
30
Graz
2021-08-17
By invitation
Viatris Innovation GmbH
Phase 3
25,000
Graz, Klagenfurt, Sankt Pölten, Vienna
2021-08-14
Active, closed
HUYABIO International, LLC.
Phase 3
450
Graz, Innsbruck
2021-08-12
Active, closed
Biotronik AG
Observational
160
Graz
2021-08-10
Recruiting
University Medicine Greifswald
Observational
3,000
Salzburg
2021-08-06
Active, closed
AstraZeneca
Phase 3
712
Graz, Krems, Linz, Vienna, Wiener Neustadt
2021-08-05
Active, closed
Assistance Publique - Hôpitaux de Paris
Phase 3
800
Linz
2021-08-04
Active, closed
Boston Scientific Corporation
Phase 4
544
Innsbruck, Sankt Pölten, Vienna
2021-08-02
Recruiting
Medical University of Vienna
Observational
90
Vienna
2021-07-26
Active, closed
Boston Scientific Corporation
Not applicable
297
Linz
2021-07-20
Recruiting
Comparison of Computertomography Scan, Electrical Impedance Tomography, and Ultrasound of the Lung in Infants
NCT04989439Infant ALL, Computed Tomography, Electric Impedance, Ultrasonography
Medical University of Vienna
Observational
10
Vienna
2021-07-19
Active, closed
A Study to Evaluate Tabelecleucel in Participants With Epstein Barr Virus (EBV) Associated Diseases
NCT04554914Epstein-Barr Virus (EBV)-Associated Diseases, EBV+ Lymphoproliferative Disease With Primary Immunodeficiency (EBV+ PID LPD), EBV+ Lymphoproliferative Disease With Acquired (Non-congenital) Immunodeficiency (EBV+ AID LPD), EBV+ Posttransplant Lymphoproliferative Disease in Central Nervous System (EBV+ CNS PTLD)
DrugTabelecleucel
Pierre Fabre Medicament
Phase 2
190
Salzburg, Vienna, Graz
2021-07-14
Active, closed
Hoffmann-La Roche
Phase 3
451
Graz, Vienna
2021-07-14
Active, closed
Evaluation of TAVR Using the NAVITOR Valve in a Global Investigation
NCT04788888Symptomatic Severe Aortic Stenosis
Abbott Medical Devices
Not applicable
434
Linz, Vienna
2021-07-13
Recruiting
Valved Graft PMCF Study
NCT04754217Aortic Valve Disease, Ascending Aorta Abnormality, Aortic Dissection
Abbott Medical Devices
Observational
260
Vienna
2021-07-13
Recruiting
Liver Transplantation in Patients With CirrHosis and Severe Acute-on-Chronic Liver Failure: iNdications and outComEs
NCT04613921Liver Diseases, Liver Cirrhosis, Acute-On-Chronic Liver Failure, Liver Transplant; Complications
European Foundation for Study of Chronic Liver Failure
Observational
3,000
Vienna
2021-07-08
Active, closed
Ethicon, Inc.
Observational
198
Linz
2021-07-07
Active, closed
Britannia Pharmaceuticals Ltd.
Observational
312
Graz, Hermagor, Innsbruck, Linz
2021-07-06
Recruiting
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
Phase 3
434
Graz, Innsbruck, Klagenfurt, Linz, Sankt Pölten, Vienna
2021-07-06
Active, closed
Helios Health Institute GmbH
Not applicable
250
Innsbruck
2021-07-05
Recruiting
Boehringer Ingelheim
Phase 1
554
Linz
2021-07-02
Active, closed
Medical University of Vienna
Observational
350
Vienna
2021-07-01
Active, closed
Implementation of a Clinical Screening and Response System for Cardiac Complications After Noncardiac Surgery
NCT05859620Myocardial Injury, Myocardial Infarction, Perioperative Complication
University Hospital, Basel, Switzerland
Observational
900
Innsbruck
2021-07-01
Active, closed
AstraZeneca
Phase 3
315
Graz, Innsbruck, Salzburg, Vienna
2021-06-30
Recruiting
A Trial to Assess Haploidentical T-depleted Stem Cell Transplantation in Patients With SCD
NCT04201210HbS Disease, Hemoglobin S Disease, Sickle Cell Anemia, Sickle Cell Disorders
University of Regensburg
Phase 2
212
Vienna
2021-06-30
Recruiting
Corcym S.r.l
Observational
2,150
Innsbruck
2021-06-29
Active, closed
GlaxoSmithKline
Phase 3
40
Feldkirch, Innsbruck, Steyr, Vienna
2021-06-28
Recruiting
Penumbra Inc.
Observational
1,500
Graz
2021-06-25
Active, closed
Mirati Therapeutics Inc.
Phase 3
461
Innsbruck, Vienna, Wiener Neustadt
2021-06-24
Active, closed
Merck Sharp & Dohme LLC
Phase 3
342
Wiener Neustadt, Vienna, Graz, Innsbruck, Salzburg
2021-06-18
By invitation
Philips Clinical & Medical Affairs Global
Not applicable
3,212
Feldkirch
2021-06-17
Active, closed
Novartis Pharmaceuticals
Phase 3
1,144
Innsbruck, Linz, Vienna
2021-06-09
Recruiting
Medical University of Vienna
Not applicable
48
Vienna
2021-06-01
Active, closed
McGill University Health Centre/Research Institute of the McGill University Health Centre
Not applicable
617
Graz, Linz
2021-06-01
Recruiting
Medical University of Vienna
Observational
700
Vienna
2021-06-01
Active, closed
Nobel Biocare
Observational
1,000
Vienna
2021-05-26
Recruiting
A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)
NCT04844606Ulcerative Colitis, Ulcerative Colitis Chronic, Inflammatory Bowel Diseases, Crohn's Disease
DrugMirikizumab
Eli Lilly and Company
Phase 3
150
Vienna
2021-05-26
Recruiting
ShOrt neCK AAA RAndomized Trial - ESAR and FEVAR: SOCRATES
NCT04503395Aortic Aneurysm, Abdominal
FCRE (Foundation for Cardiovascular Research and Education)
Not applicable
204
Vienna
2021-05-21
Active, closed
The SELUTION DeNovo Study
NCT04859985Coronary Artery Disease
M.A. Med Alliance S.A.
Not applicable
3,326
Feldkirch, Graz, Linz
2021-05-15
Active, closed
Bayer
Observational
62
Multiple Locations
2021-05-14
Active, closed
Medical University Innsbruck
Phase 2
33
Innsbruck
2021-05-12
Active, closed
Incyte Corporation
Phase 3
899
Innsbruck, Linz, Rankweil, Sankt Pölten, Vienna
2021-05-11
Active, closed
Hoffmann-La Roche
Observational
800
Klagenfurt, Vienna
2021-05-10
Active, closed
Hoffmann-La Roche
Phase 2
586
Graz, Innsbruck, Vienna
2021-05-05
Active, closed
Hoffmann-La Roche
Phase 3
1,188
Innsbruck, Linz, Salzburg
2021-05-04
Active, closed
Murdoch Childrens Research Institute
Not applicable
906
Feldkirch
2021-05-04
Active, closed
Abbott Medical Devices
Observational
200
Linz
2021-05-04
Active, closed
St. Josefs-Hospital Wiesbaden GmbH
Not applicable
196
Innsbruck
2021-05-01
Recruiting
Erasmus Medical Center
Not applicable
600
Vienna
2021-05-01
Recruiting
Database for Interstitial Lung Disease
NCT04707781Lung Diseases, Interstitial
Medical University of Graz
Observational
412
Graz
2021-05-01
Recruiting
Ipsen
Phase 1/2
240
Innsbruck, Linz, Vienna
2021-04-29
Recruiting
Medical University of Graz
Observational
150
Graz
2021-04-28
Active, closed
Hoffmann-La Roche
Phase 3
557
Innsbruck, Salzburg, Sankt Pölten, Vienna
2021-04-26
Recruiting
RESTORE - Study of AGN1 LOEP to Prevent Secondary Hip Fractures
NCT04796350Fragility Fracture, Hip Fractures, Osteoporosis
AgNovos Healthcare, LLC
Not applicable
2,400
Innsbruck
2021-04-24
Recruiting
GlaxoSmithKline
Phase 2
37
Graz, Vienna
2021-04-16
Recruiting
Tendyne European Experience Registry
NCT04898335Mitral Regurgitation
LMU Klinikum
Observational
400
Linz, Vienna
2021-04-15
Active, closed
Incyte Corporation
Phase 3
654
Graz, Innsbruck, Linz, Vienna
2021-04-15
Active, closed
Takeda
Phase 3
77
Vienna
2021-04-14
Active, closed
Jena University Hospital
Not applicable
478
Vienna, Graz, Klagenfurt
2021-04-13
Active, closed
Geron Corporation
Phase 3
327
Wein, Linz, Wels
2021-04-12
Active, closed
Phase 3 Study of Pelabresib (CPI-0610) in Myelofibrosis (MF) (MANIFEST-2)
NCT04603495Myelofibrosis, Primary Myelofibrosis, Post-polycythemia Vera Myelofibrosis, Post-essential Thrombocythemia Myelofibrosis
DrugsPelabresib·Ruxolitinib
Novartis Pharmaceuticals
Phase 3
430
Graz, Linz, Salzburg
2021-04-09
Active, closed
Loxo Oncology, Inc.
Phase 3
500
Salzburg, Linz
2021-04-08
Recruiting
CRP Apheresis in STEMI
NCT04939805ST Elevation Myocardial Infarction, C-Reactive Protein, Apheresis, Myocardial Injury
Medical University Innsbruck
Not applicable
202
Graz, Innsbruck, Salzburg
2021-04-01
Active, closed
Novo Nordisk A/S
Phase 3
1,205
Graz, Saint Stefan, Salzburg, Vienna, Wels
2021-04-01
Recruiting
Boston Scientific Corporation
Observational
5,000
Graz
2021-03-29
Active, closed
Hoffmann-La Roche
Phase 3
751
Linz
2021-03-24
Recruiting
Maastricht University Medical Center
Observational
350
Vienna
2021-03-16
Active, closed
CTC Quantification During TURBT and PKVBT of Transitional Cell Carcinoma in Purging Fluid and Blood
NCT04811846Urinary Bladder Neoplasm, Transitional Cell Carcinoma, Urogenital Neoplasms, Circulating Tumor Cell
University Teaching Hospital Hall in Tirol
Not applicable
40
Hall in Tirol, Salzburg
2021-03-14
Recruiting
Post Market Clinical Follow up Study With the Cervical Disc Prothesis MOVE®-C
NCT05035693Discopathy, Herniated Cervical Disc, Stenoses, Spinal, Radiculopathy
NGMedical GmbH
Not applicable
170
Vienna
2021-03-11
Active, closed
Loxo Oncology, Inc.
Phase 3
238
Salzburg, Linz, Vienna
2021-03-09
Recruiting
Medical University of Vienna
Phase 4
290
Vienna
2021-03-01
Active, closed
German CLL Study Group
Phase 3
897
Graz, Innsbruck, Vienna
2021-03-01
Recruiting
Medical University of Graz
Observational
80
Graz
2021-02-26
Active, closed
Merck Sharp & Dohme LLC
Phase 3
747
Vienna, Graz, Linz
2021-02-25
Active, closed
Celgene
Phase 3
313
Graz, Linz, Vienna
2021-02-25
Active, closed
Mirati Therapeutics Inc.
Phase 3
453
Klagenfurt, Salzburg, Vienna
2021-02-23
Active, closed
University of Kiel
Observational
2,300
Wiener Neustadt
2021-02-22
Recruiting
Biosense Webster, Inc.
Observational
8,000
Graz, Linz, Wiener Neustadt
2021-02-22
Active, closed
Hoffmann-La Roche
Phase 3
55
Vienna
2021-02-04
Active, closed
HERTHENA-Lung01: Patritumab Deruxtecan in Subjects With Metastatic or Locally Advanced EGFR-mutated Non-Small Cell Lung Cancer
NCT04619004Non-Small Cell Lung Cancer Metastatic, Non-Small Cell Lung Cancer With Mutation in Epidermal Growth Factor Receptor
DrugPatritumab deruxtecan
Daiichi Sankyo
Phase 2
277
Vienna
2021-02-02
Active, closed
Go Fit Fast, Recovery Trajectory Using PROMIS®, Linking PROMIS®
NCT04113044Hip Fractures, Tibial Fractures, Ankle Fractures, Humeral Fracture, Proximal
AO Innovation Translation Center
Observational
1,500
Innsbruck
2021-02-01
Recruiting
Epygon
Not applicable
40
Innsbruck, Vienna
2021-02-01
Recruiting
SCAD : a Registry of Spontaneous Coronary Artery Dissection
NCT06601270Spontaneous Coronary Artery Dissection
European Society of Cardiology
Observational
1,500
Innsbruck, Vienna, Wiener Neustadt
2021-01-30
Active, closed
AstraZeneca
Phase 3
1,371
Feldkirch, Salzburg, Vienna
2021-01-28
Active, closed
Pfizer
Phase 3
257
Graz
2021-01-15
Active, closed
Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company
Observational
5,000
Dornbirn, Feldkirch, Graz, Hörsching, Innsbruck, Klagenfurt, Linz, Mattersburg
2021-01-15
Active, closed
Lasertherapy for Vulvodynia
NCT04711369Vulvodynia
Medical University of Graz
Not applicable
92
Graz
2021-01-15
Active, closed
Toralf Reimer, MD PhD
Not applicable
350
Graz
2021-01-13
Active, closed
Genmab
Phase 3
483
Linz, Salzburg
2021-01-13
Active, closed
Galderma R&D
Phase 3
500
Graz, Linz, Vienna
2021-01-11
Active, closed
Merck Sharp & Dohme LLC
Phase 3
990
Graz, Innsbruck
2021-01-10
Recruiting
Medical University of Graz
Not applicable
219
Graz
2021-01-07
Active, closed
BioNTech SE
Phase 2/3
358
Graz, Innsbruck, Linz, Salzburg
2021-01-07
Active, closed
Amgen
Phase 1/2
181
Vienna
2021-01-04
Active, closed
Medical University Innsbruck
Observational
1,000
Innsbruck, Münster
2021-01-01
Recruiting
Medical University Innsbruck
Observational
5,000
Innsbruck, Münster
2021-01-01
Recruiting
Effect of Fetal Aortic Valvuloplasty on Outcomes
NCT05386173Congenital Heart Disease, Aortic Valve Stenosis, Fetal Cardiac Disorder, Hypoplastic Left Heart Syndrome
Queen Silvia Children's Hospital, Gothenburg, Sweden
Observational
200
Linz
2021-01-01
Recruiting
Echocardiographic Predictors of Atrial Fibrillation
NCT05044208Atrial Fibrillation, Stroke, Ischemic, Embolic Stroke of Undetermined Source, TIA, Brain
Karl Landsteiner University of Health Sciences
Observational
200
Tulln
2021-01-01
Recruiting
Real-Life Chronic Rhinosinusitis Outcome Registry
NCT04670172Chronic Rhinosinusitis (Diagnosis)
Change Accelerator in Respiratory Care
Observational
4,550
Graz, Vienna
2021-01-01
Active, closed
Characteristics of Pulmonary Vascular Changes in Patients With Kidney Transplantation
NCT04842591Pulmonary Hypertension, Kidney Transplantation, Haemodialysis
Medical University of Graz
Observational
60
Graz
2020-12-23
Active, closed
Stryker Neurovascular
Observational
405
Salzburg
2020-12-21
Active, closed
AstraZeneca
Phase 3
358
Graz, Vienna
2020-12-16
Active, closed
Neurocrine Biosciences
Phase 3
182
Graz, Vienna
2020-12-16
Active, closed
Universität Münster
Phase 2
190
Innsbruck, Linz, Salzburg, Vienna
2020-12-10
Active, closed
Stroke-Card Registry
NCT04582825Ischemic Stroke, Transient Ischemic Attack
VASCage GmbH
Observational
5,000
Vienna, Innsbruck
2020-12-09
Active, closed
Janssen Research & Development, LLC
Phase 3
518
Linz, Salzburg, Vienna
2020-12-07
Active, closed
JOTEC GmbH
Observational
163
Vienna
2020-12-03
Active, closed
Assessment of the Axone Micro Quadripolar Lead for Enhanced Cardiac Resynchronization Therapy
NCT04463641Heart Failure, Cardiac Resynchronization Therapy
MicroPort CRM
Not applicable
92
Linz
2020-12-03
Recruiting
Mirati Therapeutics Inc.
Phase 2/3
626
Klagenfurt, Krems, Linz, Vienna
2020-12-02
Active, closed
University Hospital, Basel, Switzerland
Not applicable
64,374
Vienna
2020-12-01
Active, closed
XVIVO Perfusion
Not applicable
230
Vienna
2020-11-25
Active, closed
Janssen Pharmaceutica N.V., Belgium
Phase 3
691
Linz, Salzburg, Vienna
2020-11-12
Active, closed
Bayer
Phase 4
654
Vienna, Linz
2020-11-09
Recruiting
Vyxeos® With Clofarabine for Pediatric AML
NCT07156435Relapsed Pediatric AML, Refractory Pediatric AML
DrugClofarabine
Princess Maxima Center for Pediatric Oncology
Phase 1
25
Vienna
2020-11-06
Recruiting
MAintenance Therapy With Aromatase Inhibitor in Epithelial Ovarian Cancer (MATAO)
NCT04111978Ovarian Neoplasm Epithelial, Fallopian Tube Neoplasms, Peritoneal Neoplasms, High-grade Serous Ovarian Carcinoma (HGSOC)
DrugLetrozole
Swiss GO Trial Group
Phase 3
540
Graz, Innsbruck, Leoben, Linz, Salzburg, Vienna
2020-11-05
Active, closed
Alexion Pharmaceuticals, Inc.
Phase 3
281
Linz, Vienna
2020-11-03
Recruiting
CHoice of OptImal transCatheter trEatment for Mitral Insufficiency Registry
NCT04688190Mitral Regurgitation, Mitral Valve Disease, Mitral Annular Calcification
Universitätsklinikum Hamburg-Eppendorf
Observational
1,000
Vienna
2020-11-01
Active, closed
Sacituzumab Govitecan in Primary HER2-negative Breast Cancer
NCT04595565HER2-negative Breast Cancer, Triple Negative Breast Cancer
DrugsXeloda·Sacituzumab Govitecan·Paraplatin·Capecitabine
GBG Forschungs GmbH
Phase 3
1,332
Graz, Innsbruck, Linz, Salzburg, Sankt Pölten, Vienna, Vöcklabruck, Wels
2020-10-28
Active, closed
Pfizer
Observational
1,407
Braunau am Inn, Innsbruck, Klagenfurt, Salzburg, Sankt Pölten, Schwaz, Vienna
2020-10-27
Active, closed
Hoffmann-La Roche
Phase 3
985
Linz, Vienna
2020-10-26
Recruiting
Abbott Vascular Medical Device Registry
NCT04573660Acute Myocardial Infarction, Restenoses, Coronary, Coronary Artery Lesions, Venous Embolism
Abbott Medical Devices
Observational
3,784
Graz
2020-10-25
By invitation
Novo Nordisk A/S
Observational
60
Vienna
2020-10-23
Active, closed
Bayer
Phase 3
774
Vienna
2020-10-20
Active, closed
Exelixis
Phase 3
575
Linz, Vienna
2020-10-19
Active, closed
Hoffmann-La Roche
Phase 3
992
Salzburg, Steyr, Vienna
2020-10-09
Recruiting
Prolacta Bioscience
Not applicable
200
Innsbruck
2020-10-09
Active, closed
Acerta Pharma BV
Phase 3
611
Linz, Wels
2020-10-08
Active, closed
AstraZeneca
Phase 3
370
Linz
2020-10-02
Recruiting
Patient Experience Data in Radiation Oncology
NCT05224297Radiotherapy Side Effect, PROMs
Medical University of Vienna
Observational
6,000
Vienna
2020-10-01
Recruiting
CGRP Inhibition, Autonomic Function, and Migraine
NCT04628429Episodic Migraine, Chronic Migraine
DrugsErenumab·Fremanezumab·Galcanezumab
Medical University of Vienna
Observational
120
Vienna
2020-10-01
Active, closed
AbbVie
Phase 3
527
Sankt Pölten, Vienna, Linz
2020-09-30
Active, closed
University of Zurich
Not applicable
986
Klagenfurt
2020-09-30
Active, closed
argenx
Phase 2
229
Innsbruck, Linz, Vienna
2020-09-18
Recruiting
University of Birmingham
Phase 1/2
1,672
Linz, Vienna
2020-09-17
Recruiting
EBG MedAustron GmbH
Not applicable
10
Wiener Neustadt
2020-09-14
Active, closed
AbbVie
Phase 3
531
Vienna, Linz, Wels, Salzburg
2020-09-10
Recruiting
Incidence of Silent Atrial Fibrillation in Patients With Clinically Silent Brain Ischemic Lesions
NCT04449523Silent Stroke, Silent Cerebral Infarct, Fibrillation
Insel Gruppe AG, University Hospital Bern
Observational
150
Graz
2020-09-08
Recruiting
Pierre Fabre Pharma GmbH
Observational
500
Braunau am Inn, Linz, Feldkirch, Vienna
2020-09-03
Recruiting
Isabelle Opitz, Professor, MD
Not applicable
120
Vienna
2020-09-01
Active, closed
AbbVie
Phase 3
330
Sankt Pölten, Vienna, Graz, Linz, Wels
2020-08-31
Recruiting
Malmö University
Observational
650
Vienna
2020-08-30
Active, closed
Abbott Medical Devices
Observational
511
Graz
2020-08-27
Active, closed
Alexion Pharmaceuticals, Inc.
Phase 3
125
Linz, Vienna
2020-08-25
Active, closed
Combination of Ranibizumab and Targeted Laser Photocoagulation
NCT04444492Central Retinal Vein Occlusion With Macular Edema
DrugsLucentis·Ranibizumab
University of Giessen
Phase 3
88
Innsbruck
2020-08-25
Active, closed
Incyte Corporation
Phase 2
112
Vienna
2020-08-03
Active, closed
University Hospital, Basel, Switzerland
Not applicable
382
Salzburg, Vienna
2020-07-28
Active, closed
AstraZeneca
Phase 3
866
Graz, Innsbruck
2020-07-24
Active, closed
AstraZeneca
Phase 3
134
Innsbruck
2020-07-20
Active, closed
Celgene
Phase 2
276
Vienna
2020-07-14
Recruiting
Austrian Myeloid Registry
NCT04438889Myeloid Diseases
Arbeitsgemeinschaft medikamentoese Tumortherapie
Observational
3,000
Feldkirch, Graz, Innsbruck, Krems, Leoben, Linz, Salzburg, Sankt Pölten
2020-07-13
Active, closed
AstraZeneca
Phase 3
1,012
Graz, Linz, Salzburg
2020-07-13
Recruiting
Noninvasive Cardiovascular Diagnosis of Patients With Fully Magnetically Levitated Blood Pumps
NCT04641416End-stage Heart Failure, Cardiomyopathies, Mechanical Circulatory Support
Thomas Schlöglhofer, PhD, MSc
Observational
60
Vienna
2020-07-09
Active, closed
RETHINK REFLUX Registry
NCT04253392Gastroesophageal Reflux
Ethicon Endo-Surgery
Observational
500
Vienna
2020-07-08
Recruiting
AUVA
Not applicable
246
Innsbruck, Bad Häring, Feldkirch, Graz, Klagenfurt, Klosterneuburg, Linz, Salzburg
2020-07-02
Active, closed
Supramarginal Resection in Glioblastoma
NCT04243005Glioblastoma
St. Olavs Hospital
Not applicable
90
Vienna
2020-07-01
Recruiting
Vienna HIV Infection Via Sex Study
NCT05326061HIV Infections, HIV Pre-Exposure Prophylaxis, Sexually Transmitted Diseases, Gonorrhea
Medical University of Vienna
Observational
500
Vienna
2020-07-01
Recruiting
Michael J. Fox Foundation for Parkinson's Research
Observational
4,500
Innsbruck
2020-07-01
Active, closed
SAPIEN 3 Ultra System PMCF
NCT04555967Aortic Valve Stenosis
Edwards Lifesciences
Observational
200
Vienna
2020-06-30
Active, closed
Actelion
Phase 3
935
Graz, Linz, Vienna
2020-06-30
Active, closed
Eli Lilly and Company
Phase 3
996
Salzburg, Vienna, Innsbruck
2020-06-22
Recruiting
International CIPN Assessment and Validation Study
NCT04633655Chemotherapy-induced Peripheral Neuropathy, Quality of Life
University of Milano Bicocca
Observational
1,000
Vienna
2020-06-08
Recruiting
Medical University of Graz
Not applicable
39
Graz
2020-05-27
Recruiting
University Hospital Heidelberg
Phase 1/2
91
Vienna
2020-05-26
Active, closed
Universitätsklinikum Hamburg-Eppendorf
Phase 2
24
Graz
2020-05-18
Active, closed
First in Men Study: BIOMAG-I
NCT04157153Coronary Artery Disease
Biotronik AG
Not applicable
116
Graz
2020-04-27
Recruiting
Karl Landsteiner Institute for Lung Research and Pneumological Oncology
Observational
500
Vienna
2020-04-17
Recruiting
Anxiety, Stress and Pain & Myocardial Infarction
NCT04130269Myocardial Infarction
Medical University of Graz
Observational
100
Graz
2020-04-07
Active, closed
Bayer
Observational
54
Many Locations
2020-04-03
Recruiting
Medical University of Vienna
Not applicable
108
Vienna
2020-03-09
Recruiting
TUBectomy With Delayed Oophorectomy in High Risk Women to Assess the Safety of Prevention
NCT04294927BRCA1 Gene Mutation, BRCA2 Gene Mutation, RAD51C Gene Mutation, RAD51D Gene Mutation
University Medical Center Nijmegen
Not applicable
3,000
Graz
2020-03-01
Recruiting
Prospective Registry of Eosinophilia With Respiratory Manifestations With Translational Research Identifying and Characterizing Eosinophils
NCT04538937Eosinophilic Asthma, EGPA - Eosinophilic Granulomatosis With Polyangiitis, Samter Triad, HES - Hypereosinophilic Syndrome
Medical University Innsbruck
Observational
300
Innsbruck
2020-02-26
Active, closed
Immunocore Ltd
Phase 1/2
410
Salzburg
2020-02-25
Recruiting
German CLL Study Group
Phase 2
83
Vienna
2020-02-19
Active, closed
KANDO Research
Not applicable
302
Graz, Vienna
2020-02-18
By invitation
Global Utilization And Registry Database for Improved heArt preservatioN
NCT04141605Heart Diseases, Heart Failure, Heart Defects, Congenital
Paragonix Technologies
Observational
4,000
Graz, Vienna
2020-02-14
Active, closed
Bayer
Observational
805
Multiple Locations
2020-01-30
Recruiting
Medtronic Cardiac Surgery
Observational
5,000
Vienna
2020-01-09
Active, closed
Goethe University
Phase 2
180
Graz
2020-01-07
Recruiting
Medical University Innsbruck
Not applicable
25
Innsbruck
2020-01-01
Active, closed
CMR-AI and Outcomes in AS
NCT06128876Aortic Stenosis
Medical University of Vienna
Observational
1,500
Vienna
2020-01-01
Active, closed
Stichting Hemato-Oncologie voor Volwassenen Nederland
Phase 3
777
Graz, Innsbruck, Linz, Salzburg, Vienna
2019-12-20
Active, closed
Sotorasib Activity in Subjects With Advanced Solid Tumors With KRAS p.G12C Mutation (CodeBreak 101)
NCT04185883Advanced Solid Tumors, Kirsten Rat Sarcoma (KRAS) pG12C Mutation
DrugsBI 1701963·TNO155·Afatinib·Sotorasib
Amgen
Phase 1
610
Graz, Salzburg
2019-12-17
Active, closed
Christian Buske
Phase 2
36
Vienna
2019-12-15
Active, closed
C. R. Bard
Not applicable
477
Graz
2019-12-12
Active, closed
Institut für Pharmakologie und Präventive Medizin
Observational
500
Innsbruck, Linz, Salzburg, Wels
2019-12-12
Active, closed
Cold Agglutinin Disease Real World Evidence Registry
NCT05791708Cold Agglutinin Disease (CAD), Cold Agglutinin Syndrome (CAS)
RECORDATI GROUP
Observational
429
Salzburg, Vienna
2019-12-12
Recruiting
Connective Tissue Diseases and Lung Manifestations
NCT04095351Connective Tissue Diseases, Interstitial Lung Disease, Systemic Sclerosis
DrugBlood sampling
Medical University Innsbruck
Observational
120
Innsbruck
2019-12-09
Recruiting
Medtronic Cardiac Surgery PMCF Registry
NCT04073420Valve Disease, Heart
Medtronic Cardiac Surgery
Observational
2,700
Vienna
2019-12-02
Recruiting
Alexion Pharmaceuticals, Inc.
Observational
500
Vienna
2019-12-02
Active, closed
Alnylam Pharmaceuticals
Phase 3
655
Graz, Vienna
2019-11-26
Active, closed
Surveillance AFter Extremity Tumor surgerY
NCT03944798Soft Tissue Sarcoma, Lung Metastases
McMaster University
Not applicable
310
Graz
2019-11-19
Recruiting
Medical University of Vienna
Observational
30
Vienna
2019-11-18
Active, closed
Matched Unrelated vs. Haploidentical Donor for Allogeneic Stem Cell Transplantation in Patients With Acute Leukemia
NCT04232241Acute Myeloid Leukemia in Remission, Acute Lymphoblastic Leukemia in Remission, Myelodysplastic Syndromes
Universitätsklinikum Hamburg-Eppendorf
Phase 2
167
Graz, Innsbruck, Vienna
2019-11-14
Recruiting
APrevent Biotech GmbH
Not applicable
30
Vienna
2019-11-13
Recruiting
High-Risk Neuroblastoma Study 2 of SIOP-Europa-Neuroblastoma (SIOPEN)
NCT04221035High-Risk Neuroblastoma, Patient With Insufficient Response Chemoimmunotherapy
DrugsDinutuximab beta·Vindesine·Cyclophosphamid·Thiotepa
Gustave Roussy, Cancer Campus, Grand Paris
Phase 3
800
Graz, Innsbruck, Linz, Salzburg, Vienna
2019-11-05
Active, closed
Balt Extrusion
Observational
234
Salzburg
2019-11-04
Active, closed
Micro Medical Solution, Inc.
Observational
300
Graz
2019-10-31
By invitation
Rigel Pharmaceuticals
Phase 3
90
Vienna
2019-10-30
Active, closed
Bristol-Myers Squibb
Phase 3
790
Graz, Innsbruck, Salzburg, Vienna
2019-10-28
Active, closed
University of Southampton
Observational
429
Vienna
2019-10-28
Recruiting
Boston Scientific Corporation
Observational
500
Innsbruck
2019-10-23
Active, closed
Novo Nordisk A/S
Phase 3
134
Vienna
2019-10-21
Recruiting
Pierre Fabre Pharma GmbH
Observational
750
Graz, Innsbruck, Klagenfurt, Linz, Salzburg, Vienna, Wiener Neustadt
2019-10-17
Recruiting
Dr. Rebecca Schule
Observational
2,000
Innsbruck
2019-10-14
Active, closed
SyncAV Post-Market Trial
NCT04100148Congestive Heart Failure
Abbott Medical Devices
Not applicable
1,686
Graz
2019-10-03
Active, closed
Seagen, a wholly owned subsidiary of Pfizer
Phase 3
466
Innsbruck, Vienna
2019-10-02
Active, closed
University of Zurich
Observational
540
Vienna
2019-10-01
Active, closed
NeuroDerm Ltd.
Phase 3
381
Innsbruck
2019-09-30
By invitation
A Study for Participants Who Participated in Prior Clinical Studies of ASTX727 (Standard Dose)
NCT04093570Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia, Myelodysplastic Syndromes
DrugDecitabine
Taiho Oncology, Inc.
Phase 2
332
Vienna
2019-09-30
Active, closed
RECORDATI GROUP
Observational
125
Vienna
2019-09-30
Active, closed
Janssen Research & Development, LLC
Phase 2/3
1,064
Salzburg
2019-09-26
By invitation
A Study Evaluating the Long-Term Efficacy and Safety of Ralinepag in Subjects With PAH Via an Open-Label Extension
NCT03683186PAH, Pulmonary Hypertension, Pulmonary Arterial Hypertension, Hypertension
United Therapeutics
Phase 3
1,000
Innsbruck, Linz, Vienna
2019-09-23
Active, closed
An Extension Study of Venetoclax for Subjects Who Have Completed a Prior Venetoclax Clinical Trial
NCT03844048Chronic Lymphocytic Leukemia, Acute Myeloid Leukemia, Multiple Myeloma, Non-Hodgkin's Lymphoma
DrugsVenclexta·Venetoclax
AbbVie
Phase 3
165
Graz
2019-09-06
Active, closed
Pfizer
Phase 3
896
Vienna
2019-09-05
Active, closed
University of Ulm
Phase 3
882
Graz, Innsbruck, Linz, Rankweil, Salzburg, Vienna
2019-09-04
Active, closed
ETOP IBCSG Partners Foundation
Phase 3
405
Graz, Innsbruck, Salzburg, Vienna
2019-08-27
Recruiting
University Hospital Muenster
Phase 3
683
Graz, Innsbruck, Linz, Salzburg, Vienna
2019-08-23
Active, closed
MiCLASP Post Market Clinical Follow-Up (PMCF) Study
NCT04430075Mitral Regurgitation, Mitral Insufficiency
Edwards Lifesciences
Observational
1,000
Vienna
2019-08-23
Active, closed
BeOne Medicines
Phase 3
510
Linz, Salzburg, Vienna
2019-08-20
Recruiting
Bristol-Myers Squibb
Phase 2
1,500
Graz, Linz, Sankt Pölten, Vienna, Wels
2019-08-09
Active, closed
Bristol-Myers Squibb
Phase 3
839
Graz, Linz, Salzburg, Vienna, Wiener Neustadt
2019-08-05
Active, closed
Thomas Wekerle
Phase 1/2
12
Vienna
2019-08-01
Active, closed
Novo Nordisk A/S
Phase 2
62
Linz, Graz, Salzburg, Sankt Pölten, Vöcklabruck
2019-07-04
Active, closed
Phase I/II Study of Rapcabtagene Autoleucel in CLL, 3L+ DLBCL, r/r ALL and 1L HR LBCL
NCT03960840Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Diffuse Large B-cell Lymphoma, Acute Lymphoblastic Leukemia
DrugIbrutinib
Novartis Pharmaceuticals
Phase 1/2
218
Vienna
2019-06-26
Active, closed
Exelixis
Phase 3
855
Wiener Neustadt, Linz, Salzburg, Vienna
2019-06-25
Recruiting
European Organisation for Research and Treatment of Cancer - EORTC
Observational
2,000
Graz, Linz, Vienna
2019-06-24
Active, closed
Bristol-Myers Squibb
Phase 3
437
Graz, Vienna, Wels
2019-06-21
Active, closed
Sanofi
Observational
955
Graz, Linz, Maria Enzersdorf, Vienna
2019-06-11
Active, closed
Nuvaira, Inc.
Not applicable
464
Vienna
2019-05-23
Recruiting
Custodiol-N Solution Compared With Custodiol Solution in Organ Transplantation (Kidney, Liver and Pancreas)
NCT03627013Kidney Failure, Liver Failure, Chronic, Kidney-Pancreas Failure
DrugCustodiol-N
Dr. F. Köhler Chemie GmbH
Phase 3
362
Graz, Innsbruck, Linz, Vienna
2019-05-23
Active, closed
Celgene
Phase 1/2
438
Salzburg, Sankt Pölten, Vienna
2019-05-20
Recruiting
Medical University of Graz
Observational
266
Graz
2019-05-02
Active, closed
Inspiris Resilia Durability Registry
NCT03666741Aortic Valve Stenosis
Institut für Pharmakologie und Präventive Medizin
Observational
400
Sankt Pölten, Vienna
2019-04-26
Recruiting
Eli Lilly and Company
Phase 3
190
Bregenz
2019-04-05
By invitation
Novo Nordisk A/S
Observational
60
Vienna
2019-04-01
Active, closed
Automatic PredICtion of Edema After Stroke
NCT04057690Stroke, Acute, Brain Edema
University Hospital Tuebingen
Observational
1,687
Vienna
2019-04-01
Active, closed
Madrigal Pharmaceuticals, Inc.
Phase 3
1,759
Klagenfurt, Vienna, Linz, Salzburg, Sankt Pölten, Wels
2019-03-28
Active, closed
Institut de Recherches Internationales Servier
Phase 3
856
Graz, Innsbruck, Linz, Salzburg, Sankt Pölten, Vienna
2019-03-21
Active, closed
Stichting Hemato-Oncologie voor Volwassenen Nederland
Phase 3
968
Graz, Innsbruck, Linz, Vienna
2019-03-01
Active, closed
Medical University of Vienna
Not applicable
60
Vienna
2019-03-01
Recruiting
ESAN II - Energy Sensing in Depression
NCT05432362Immune System Tolerance, Depression, Obesity, Microbial Colonization
Medical University of Graz
Not applicable
120
Graz
2019-02-25
Active, closed
Acerta Pharma BV
Phase 3
984
Krems, Salzburg, Vienna
2019-02-25
Active, closed
Follow-up in Gynecological Cancer Survivors
NCT03515993Gynecologic Cancer
European Organisation for Research and Treatment of Cancer - EORTC
Observational
1,100
Graz
2019-02-21
Active, closed
Austrian Breast & Colorectal Cancer Study Group
Not applicable
92
Salzburg, Graz, Kufstein, Braunau am Inn, Linz, Steyr, Wels
2019-02-14
Active, closed
Medical University of Graz
Not applicable
60
Graz
2019-02-13
Recruiting
Cold-induced Brown Fat Activation and Hepatic Steatosis
NCT03811236Non-Alcoholic Fatty Liver Disease
Medical University of Vienna
Not applicable
26
Vienna
2019-01-21
Recruiting
Medical University of Vienna
Not applicable
750
Vienna
2019-01-21
Recruiting
Pascoe Pharmazeutische Praeparate GmbH
Observational
1,000
Vienna, Etc.
2019-01-12
Active, closed
AstraZeneca
Phase 3
1,407
Graz, Innsbruck, Linz, Vienna
2019-01-04
Active, closed
Celgene
Phase 3
363
Linz, Vienna
2019-01-02
Active, closed
Novartis Pharmaceuticals
Phase 3
1,882
Vienna
2018-12-28
Active, closed
AstraZeneca
Phase 1
175
Salzburg, Vienna
2018-12-27
Active, closed
Merck Sharp & Dohme LLC
Phase 3
1,397
Vienna, Innsbruck, Linz, Salzburg
2018-12-24
Recruiting
Study of Individuals Affected With Hypoplasminogenemia
NCT03797495Plasminogen Deficiency
Indiana Hemophilia &Thrombosis Center, Inc.
Observational
100
Innsbruck
2018-12-18
Active, closed
Merck Sharp & Dohme LLC
Phase 3
714
Graz, Linz, Salzburg, Vienna
2018-12-17
Active, closed
Novartis Pharmaceuticals
Phase 3
5,101
Innsbruck, Graz, Linz, Salzburg, Vienna
2018-12-07
Active, closed
AstraZeneca
Phase 3
825
Graz, Innsbruck, Rankweil, Vienna
2018-12-06
Recruiting
Pulmonary Hemodynamics During Exercise - Research Network
NCT03954574Pulmonary Circulation Diseases
Medical University of Graz
Observational
1,500
Graz
2018-12-01
Recruiting
Retinal Photoreceptor Outer Segment Length Before and After Light Stimulation - a Pilot Study
NCT03921931Macular Degeneration, Dry, Primary Open-angle Glaucoma
Medical University of Vienna
Not applicable
35
Vienna
2018-11-26
Recruiting
Medical University of Vienna
Not applicable
120
Vienna
2018-11-21
Recruiting
Medical University of Vienna
Not applicable
20
Vienna
2018-11-19
Active, closed
IRCCS San Raffaele
Observational
200
Neulengbach
2018-10-30
Active, closed
Exelixis
Phase 3
187
Salzburg, Vienna
2018-10-05
Active, closed
A Study of Ponatinib Versus Imatinib in Adults With Acute Lymphoblastic Leukemia
NCT03589326Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ALL)
DrugsPonatinib·Imatinib·Cytarabine·Methotrexate
Takeda
Phase 3
245
Vienna, Linz
2018-10-04
Active, closed
Ipsen
Observational
224
Leoben, Linz, Salzburg, Vöcklabruck, Wels
2018-09-24
Recruiting
Hoffmann-La Roche
Phase 3
1,000
Graz, Vienna
2018-09-20
Active, closed
Fondazione Michelangelo
Phase 3
650
Klagenfurt, Linz, Sankt Pölten, Vienna
2018-09-07
Active, closed
Wuerzburg University Hospital
Phase 3
576
Krems, Sankt Pölten, Graz, Innsbruck, Linz, Wels, Rankweil, Salzburg
2018-08-28
Active, closed
AbbVie
Phase 3
1,242
Sankt Pölten, Vienna, Graz, Linz, Salzburg
2018-08-28
Recruiting
Merck Sharp & Dohme LLC
Phase 3
3,500
Graz, Innsbruck, Linz, Salzburg, Vienna
2018-08-21
Active, closed
Hoffmann-La Roche
Phase 3
257
Vienna
2018-08-16
Active, closed
AbbVie
Phase 3
1,533
Vienna, Innsbruck, Linz
2018-08-09
Active, closed
University Hospital, Basel, Switzerland
Not applicable
1,500
Dornbirn, Feldkirch, Innsbruck, Linz, Salzburg, Vienna, Wels
2018-08-07
Recruiting
Christoph Arnoldner
Observational
8
Vienna
2018-08-01
Active, closed
Secondary Sclerosis Cholangitis Prospective
NCT03566797Secondary Sclerosis Cholangitis in Critically Ill Patients
Medical University of Graz
Observational
380
Graz
2018-07-20
Recruiting
Celgene
Phase 2/3
1,541
Linz, Vienna
2018-07-19
Active, closed
Eli Lilly and Company
Phase 3
1,058
Innsbruck, Salzburg, Vienna
2018-07-18
Recruiting
Martin Schrappe
Phase 3
5,000
Graz, Innsbruck, Linz, Salzburg, Vienna
2018-07-15
Active, closed
AGRA Before and After Liver Transplantation
NCT03446521Liver Cirrhosis
Medical University of Graz
Observational
76
Graz
2018-07-06
Recruiting
AtriCure, Inc.
Observational
5,000
Vienna
2018-06-29
Recruiting
University of Leipzig
Not applicable
120
Graz, Vienna
2018-06-18
Active, closed
Exelixis
Phase 3
837
Klagenfurt, Sankt Pölten, Graz, Linz, Vienna
2018-06-10
Active, closed
Medical University of Graz
Observational
83
Graz
2018-06-01
Active, closed
Biotronik SE & Co. KG
Observational
3,030
Linz, Sankt Pölten, Vienna
2018-05-14
Active, closed
AstraZeneca
Phase 3
1,018
Graz, Innsbruck, Linz, Salzburg, Vienna
2018-05-14
Active, closed
Corcept Therapeutics
Phase 2
125
Vienna
2018-05-07
Active, closed
GlaxoSmithKline
Phase 2
237
Linz, Vienna
2018-05-03
Active, closed
Bristol-Myers Squibb
Phase 3
545
Graz, Vienna
2018-04-18
Active, closed
Janssen Research & Development, LLC
Phase 2/3
1,409
Salzburg, Vienna
2018-04-13
Active, closed
Bristol-Myers Squibb
Phase 2/3
714
Graz, Salzburg, Vienna
2018-04-11
Active, closed
AbbVie
Phase 3
1,336
Sankt Pölten, Vienna, Graz
2018-04-09
Recruiting
Thomas Reiberger
Observational
400
Vienna
2018-03-28
Active, closed
Janssen Research & Development, LLC
Phase 3
629
Graz, Linz, Salzburg, Vienna
2018-03-23
Recruiting
Post-Market BTVA Registry
NCT03318406Emphysema or COPD
Uptake Medical Technology, Inc.
Observational
300
Vienna
2018-03-22
Active, closed
AbbVie
Phase 3
747
Vienna, Salzburg
2018-03-21
Active, closed
Bentley InnoMed GmbH
Not applicable
18
Vienna
2018-03-01
By invitation
Medical University of Graz
Observational
100
Graz
2018-03-01
Recruiting
Retinal Neuro-vascular Coupling in Patients With Multiple Sclerosis
NCT03401879Multiple Sclerosis, Relapsing-Remitting, Optic Neuritis
Medical University of Vienna
Not applicable
50
Vienna
2018-02-01
Recruiting
Dabrafenib and/or Trametinib Rollover Study
NCT03340506Melanoma, Non Small Cell Lung Cancer, Solid Tumor, Rare Cancers
DrugsDabrafenib·Trametinib
Novartis Pharmaceuticals
Phase 4
100
Innsbruck
2018-01-26
Recruiting
Randomization of Single vs Multiple Arterial Grafts
NCT03217006Coronary Artery Disease, Heart Diseases
Weill Medical College of Cornell University
Not applicable
4,300
Innsbruck, Vienna
2018-01-07
Recruiting
Vienna Hypothermic Oxygenated Machine Perfusion Study
NCT06418165End Stage Liver Disease, Hepatocellular Carcinoma
Medical University of Vienna
Observational
500
Vienna
2018-01-01
Active, closed
University Hospital, Basel, Switzerland
Observational
797
Innsbruck
2018-01-01
Recruiting
A Phase 3 Study of Tabelecleucel for Participants With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease After Failure With Rituximab or Rituximab and Chemotherapy
NCT03394365Epstein-Barr Virus+ Associated Post-transplant Lymphoproliferative Disease (EBV+ PTLD), Solid Organ Transplant Complications, Lymphoproliferative Disorders, Allogeneic Hematopoietic Cell Transplant
DrugTabelecleucel
Pierre Fabre Medicament
Phase 3
115
Vienna
2017-12-29
Active, closed
Amgen
Phase 1
269
Graz, Salzburg
2017-12-26
Active, closed
AstraZeneca
Phase 2
528
Innsbruck, Salzburg, Vienna
2017-12-18
Recruiting
Registry for Patients With Lipodystrophy
NCT03553420Lipodystrophy Acquired, Lipodystrophy Congenital
University of Ulm
Observational
5,000
Vienna
2017-12-16
Recruiting
LivaNova
Observational
500
Vienna
2017-12-14
Active, closed
Gilead Sciences
Phase 3
340
Wels
2017-12-12
Recruiting
AbbVie
Observational
500
Sankt Pölten, Graz, Salzburg, Vienna
2017-12-04
Recruiting
Investigation of Neurovascular Coupling in Glaucoma Patients and Healthy Subjects
NCT03870230Glaucoma, Open-Angle, Normal Tension Glaucoma, Ocular Hypertension
Medical University of Vienna
Not applicable
120
Vienna
2017-12-01
Recruiting
RWTH Aachen University
Phase 2
200
Vienna
2017-11-20
Active, closed
BeiGene
Phase 3
590
Innsbruck, Linz, Salzburg, Wels
2017-10-31
Active, closed
Endurant CHevAr New Indication Trial: ENCHANT
NCT03320252AAA - Abdominal Aortic Aneurysm
Medtronic Cardiovascular
Observational
150
Linz
2017-10-26
Active, closed
Janssen-Cilag International NV
Observational
135
Graz
2017-10-25
Recruiting
Medical University of Vienna
Observational
40
Vienna
2017-10-20
Active, closed
Medical University of Graz
Phase 3
2,400
Enzenbach, Feldbach, Graz, Klagenfurt, Leoben, Linz, Schwarzach im Pongau, Vienna
2017-10-10
Active, closed
Hoffmann-La Roche
Phase 3
382
Vienna
2017-09-20
Active, closed
DePuy Orthopaedics
Not applicable
400
Linz
2017-09-19
Active, closed
Global Fenestrated Anaconda Clinical STudy
NCT03180996Abdominal Aortic Aneurysm
Vascutek Ltd.
Observational
160
Vienna
2017-09-11
Recruiting
Systematic Assessment of Laryngopharyngeal Function in Patients With Neurodegenerative Diseases
NCT04706234Multiple System Atrophy, Parkinson Disease, Progressive Supranuclear Palsy, Motor Neuron Disease
Kliniken Beelitz GmbH
Observational
350
Innsbruck
2017-09-01
Recruiting
Charite University, Berlin, Germany
Phase 2
250
Vienna
2017-09-01
Recruiting
Medical University of Vienna
Observational
340
Vienna
2017-08-31
Active, closed
Paediatric Hepatic International Tumour Trial
NCT03017326Hepatoblastoma, Carcinoma, Hepatocellular
Drugs5Fluorouracil·Sorafenib·Vincristine·Doxorubicin
University of Birmingham
Phase 3
450
Vienna
2017-08-24
Active, closed
Imatinib Mesylate and Combination Chemotherapy in Treating Patients With Newly Diagnosed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia
NCT03007147Acute Lymphoblastic Leukemia, B Acute Lymphoblastic Leukemia, Mixed Phenotype Acute Leukemia, T Acute Lymphoblastic Leukemia
DrugsL-leucovorin·Therapeutic Hydrocortisone·Levofolinate·Isophosphamide
Children's Oncology Group
Phase 3
352
Vienna
2017-08-08
Active, closed
University Hospital Muenster
Phase 3
650
Graz, Innsbruck, Klagenfurt, Linz, Salzburg, Vienna
2017-08-03
Active, closed
The Chocolate Touch Study
NCT02924857Peripheral Artery Disease (PAD), Ischemia, Intermittent Claudication
TriReme Medical, LLC
Not applicable
333
Graz, Vienna
2017-07-26
Active, closed
Eli Lilly and Company
Phase 3
5,637
Vienna, Graz, Innsbruck, Schwaz, Salzburg
2017-07-12
Active, closed
Hoffmann-La Roche
Phase 2
316
Innsbruck
2017-06-27
Active, closed
Study of AG-120 (Ivosidenib) vs. Placebo in Combination With Azacitidine in Participants With Previously Untreated Acute Myeloid Leukemia With an IDH1 Mutation
NCT03173248Newly Diagnosed Acute Myeloid Leukemia (AML), Untreated AML, AML Arising From Myelodysplastic Syndrome (MDS), Leukemia, Myeloid, Acute
DrugsIvosidenib·Azacitidine
Institut de Recherches Internationales Servier
Phase 3
146
Salzburg, Vienna
2017-06-26
Recruiting
Swiss Paediatric Airway Cohort
NCT03505216Asthma, Wheezing, Cough, Exercise Induced Bronchospasm
University of Bern
Observational
6,000
Vienna
2017-06-06
Recruiting
Diagnostic Possibilities in Ophthalmological Diseases Using Swept Source Optical Coherence Tomography
NCT06074731Retinal Disease, Diabetic Retinopathy, Macular Degeneration
Johannes Kepler University of Linz
Observational
500
Linz
2017-06-01
Active, closed
DePuy Orthopaedics
Not applicable
400
Linz
2017-05-30
Recruiting
Medical University of Vienna
Observational
300
Vienna
2017-05-30
Recruiting
Intraoperative EABR for Decision Making
NCT03745560Vestibular Schwannoma, Hearing Loss
Christoph Arnoldner
Observational
15
Vienna
2017-05-23
Active, closed
Medical University Innsbruck
Observational
64
Innsbruck
2017-05-17
Recruiting
Austrian Left Atrial Appendage Closure Registry
NCT03409159Atrial Fibrillation, Left Atrial Appendage Closure
Medical University of Graz
Observational
200
Graz
2017-05-16
Recruiting
European Organisation for Research and Treatment of Cancer - EORTC
Observational
4,975
Vienna
2017-05-03
Recruiting
Microbiome and Sarcopenia in Patients With Liver Cirrhosis
NCT03080129Sarcopenia, Liver Cirrhosis
Medical University of Graz
Not applicable
120
Graz
2017-04-11
Active, closed
AstraZeneca
Phase 3
987
Linz, Salzburg, Vienna
2017-03-27
Recruiting
Medical University of Vienna
Not applicable
12
Vienna
2017-03-23
Recruiting
Italian Sarcoma Group
Not applicable
100
Graz, Wiener Neustadt
2017-03-16
Recruiting
Nivolumab for Treatment of Squamous Cell Carcinoma of the Skin
NCT04204837Squamous Cell Carcinoma of the Skin
DrugsRelatlimab·Nivolumab
Salzburger Landeskliniken
Phase 2
61
Graz, Innsbruck, Klagenfurt, Salzburg, Sankt Pölten, Vienna, Wels
2017-03-06
Recruiting
Medical University of Graz
Observational
250
Graz
2017-03-01
Recruiting
Medical University of Graz
Phase 3
15
Graz
2017-03-01
Recruiting
Josef Ressel Centre Perinatal Programming
NCT03634930Childhood Obesity
Moenie van der Kleyn
Observational
100
Graz
2017-02-16
Active, closed
Persona Partial Knee Clinical Outcomes Study
NCT03034811Osteoarthritis, Avascular Necrosis, Traumatic Arthritis, Conditional Tibial Condyle or Plateau Fractures
Zimmer Biomet
Not applicable
757
Vienna
2017-02-08
Active, closed
Medical University Innsbruck
Observational
100
Innsbruck
2017-02-06
Active, closed
Acerta Pharma BV
Phase 3
310
Linz, Salzburg, Vienna, Wels
2017-02-02
Active, closed
ITM Solucin GmbH
Phase 3
324
Vienna
2017-02-02
Active, closed
AbbVie
Phase 3
443
Sankt Pölten, Graz, Linz, Salzburg, Vienna
2017-02-02
Recruiting
VICIS - Vienna Cirrhosis Study
NCT03267615Liver Cirrhosis, Portal Hypertension, Ascites, Variceal Hemorrhage
Medical University of Vienna
Observational
10,000
Vienna
2017-02-01
Active, closed
AbbVie
Phase 3
950
Vienna, Linz, Salzburg
2017-01-31
Active, closed
Noninvasive Mapping Before Surgical Ablation
NCT06803615Atrial Fibrillation (AF)
Medical University of Vienna
Observational
51
Vienna
2017-01-13
Active, closed
IRCCS San Raffaele
Observational
1,402
Graz, Vienna
2017-01-01
Active, closed
Astellas Pharma Global Development, Inc.
Phase 2
900
Vienna
2016-12-22
Active, closed
Janssen Biotech, Inc.
Observational
535
Salzburg, Sankt Poelten Noe, Vienna
2016-12-16
Recruiting
Fosfomycin I.v. for Treatment of Severely Infected Patients
NCT02979951Bacterial Infections, Bone Diseases, Infectious, Osteomyelitis, Central Nervous System Bacterial Infections
Infectopharm Arzneimittel GmbH
Observational
1,000
Hall in Tirol, Reutte, Vienna, Wels
2016-12
Recruiting
Neurovascular Product Surveillance Registry
NCT02988128Intracranial Aneurysm, Stroke, Ischemic
Medtronic Neurovascular Clinical Affairs
Observational
4,000
Salzburg
2016-12
Recruiting
Ion Therapy Patient Registry
NCT03049072Ion Beam Radiation Therapy for Tumor Patients
EBG MedAustron GmbH
Observational
2,800
Wiener Neustadt
2016-12
Active, closed
Eisai Inc.
Phase 3
1,069
Innsbruck, Linz, Vienna
2016-10-13
Active, closed
Tepotinib Phase II in NSCLC Harboring MET Alterations (VISION)
NCT02864992Advanced (Stage IIIB/IV) Non-small Cell Lung Cancer (NSCLC) With MET Exon 14 (METex14) Skipping Alterations or MET Amplification, Lung Adenocarcinoma Stage IIIB/IV
DrugTepotinib
EMD Serono Research & Development Institute, Inc.
Phase 2
337
Salzburg
2016-09-13
Active, closed
DePuy Orthopaedics
Not applicable
540
Ried im Innkreis
2016-09-01
Recruiting
Medical University of Vienna
Not applicable
200
Vienna
2016-08
Active, closed
AGO Study Group
Not applicable
797
Vienna
2016-07
Active, closed
PORTEC-4a: Molecular Profile-based Versus Standard Adjuvant Radiotherapy in Endometrial Cancer
NCT03469674Endometrial Cancer Stage I, Endometrial Cancer Stage II
Leiden University Medical Center
Phase 3
550
Vienna
2016-06-10
Active, closed
Eli Lilly and Company
Phase 2
309
Wiener Neustadt, Salzburg, Vienna
2016-05-19
Active, closed
NeuroDerm Ltd.
Phase 2
214
Innsbruck
2016-05-04
Recruiting
University of Alberta
Observational
700
Vienna
2016-05
Active, closed
The PREWEAN Study. Weaning of Preterm Infants During the First Year of Life.
NCT02936219Growth Failure, Atopy, Adiposity, Cognitive Impairment
Medical University of Vienna
Observational
218
Vienna
2016-04
Recruiting
Medical University of Vienna
Phase 2
1,000
Vienna
2016-04
Active, closed
REDUCER-I: An Observational Study of the Neovasc Reducer™ System
NCT02710435Angina Pectoris, Angina Pectoris, Stable, Chronic Stable Angina
Shockwave Medical, Inc.
Observational
400
Graz
2016-03
Recruiting
NT-proBNP Selected Prevention of Cardiac Events in Diabetic Patients
NCT02817360Heart Diseases, Diabetes Mellitus, Type 2
Martin Huelsmann
Phase 4
2,400
Mödling, Graz, Linz, Vienna
2016-02
Recruiting
University of Alberta
Observational
900
Vienna
2016-01
Rows per page Showing 1001–1500 of 1581
Previous 1 2 3 4 Next
Cite this view

Priya Life Science (2026). Clinical trial register: studies with an Austrian investigative site. Derived from ClinicalTrials.gov. Retrieved 13 November 2026. https://priyalifescience.com/clinical-trials-austria?page=3

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Austria and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 1,581 studies in total at the last sync on 11 Nov 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

How many clinical trials are recruiting in Austria?

849 of the 1,581 studies in this register are recruiting new participants as of the 11 Nov 2026, 03:18 UTC sync. A further 90 have not yet opened recruitment, 597 are active but closed to new participants, and 45 are enrolling by invitation only. Eligibility for any study is decided by its study team.

This register, in your inbox every Friday

One email a week with how many trials are recruiting in Ireland, new EMA and FDA approvals and medicine shortages, built from the same public registers as this page.

Free. Unsubscribe from any email with one click. See our privacy policy.

→

Browse trials by condition

Breast Cancer (22) Ulcerative Colitis (21) Multiple Myeloma (19) Crohn's Disease (16) Heart Failure (16) Atrial Fibrillation (15) Coronary Artery Disease (15) Chronic Lymphocytic Leukemia (12) Non-small Cell Lung Cancer (12) Obesity (11) Non-Small Cell Lung Cancer (11) Carcinoma, Non-Small-Cell Lung (10) Acute Myeloid Leukemia (10) Cataract (9) Liver Cirrhosis (9)
→

Browse trials by site location

Vienna (1011) Graz (514) Linz (434) Innsbruck (395) Salzburg (292) Sankt Pölten (115) Wels (90) Klagenfurt (64) Feldkirch (50) Krems (35) Wiener Neustadt (34) Rankweil (25) Leoben (25) Braunau am Inn (17) Steyr (12)
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.